In addition, the administration of EPCS (Dil-acLDL+FITC‐UEA‐I+ CD31+vWF+KDR+CD14+) isolated from T2DM patients after a 2-weeks -treatment with rosiglitazone, promoted an improved in vivo revascularization in nude mice with carotid artery injury compared to EPCs isolated from T2DM patients before the treatment [174]. This evidence concerns the gene CD14 and type 2 diabetes mellitus.